Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 1 for:    NCT03168204 | Belgium
Previous Study | Return to List | Next Study

Evaluating the Efficacy of a Detection and Prevention Program for Frail Community-dwelling Older Adults (D-SCOPE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03168204
Recruitment Status : Completed
First Posted : May 30, 2017
Last Update Posted : April 25, 2019
Sponsor:
Collaborators:
Hogeschool Gent
Universiteit Antwerpen
KU Leuven
Maastricht University
Agentschap voor Innovatie door Wetenschap en Technologie
Information provided by (Responsible Party):
Liesbeth De Donder, Vrije Universiteit Brussel

Brief Summary:
The evaluation of a detection and prevention program which aims to create a continuum of care and support for frail community-dwelling older people (from early detection, over intervention, to follow-up). First, the program aims to develop methods to easily, accurately and timely detect and prevent a negative frailty-balance in older people. Second, the study aims to improve the quality and efficacy of care and support given to frail community-dwelling older people.

Condition or disease Intervention/treatment Phase
Older Adults Behavioral: Tailored care and support Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 869 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose: Prevention
Official Title: Study Protocol of the D-SCOPE Project With a Randomized Controlled Trial, Evaluating the Efficacy of a Detection and Prevention Program for Frail Community-dwelling Older Adults
Actual Study Start Date : June 1, 2017
Actual Primary Completion Date : April 30, 2018
Actual Study Completion Date : June 30, 2018

Arm Intervention/treatment
Experimental: Risk of being frail experimental group Behavioral: Tailored care and support
Offering tailored care and support whereby the competences, strengths and resources of the older person are taken into account.The intervention will be an enhancement of usual care and will depend on the availability of the municipality, and could be formal (i.e., home care) or informal (e.g. activities of an older adult's association).

No Intervention: Risk of being frail control group
No Intervention: No/low risk of being frail
No Intervention: Risk of being frail care avoiders



Primary Outcome Measures :
  1. Change from baseline Quality of Life at 6 months [ Time Frame: Assessed during baseline testing + 6 months after inclusion ]
    One question from the WHOQOL-BREF will be used to measure the quality of life of participants (1 item). Older participants will also be asked to rate their quality of life on a scale from 0 to 10.

  2. Change from baseline Satisfaction with Life at 6 months [ Time Frame: Assessed during baseline testing + 6 months after inclusion ]
    The Satisfaction with Life Scale will be administered to explore the life satisfaction of the participants (5 items)

  3. Change from baseline sense of mastery at 6 months [ Time Frame: Assessed during baseline testing + 6 months after inclusion ]
    To assess the sense of mastery of older people, the current mastery questionnaire will be used and one self-constructed item will be added which will assess mastery in relation to others. Older participants will also be asked to rate their mastery on a scale from 0 to 10.

  4. Change from baseline Meaning in Life at 6 months [ Time Frame: Assessed during baseline testing + 6 months after inclusion ]
    Meaning in life will be evaluated with 5 items from the Meaning in Life Questionnaire (MLQ). Older participants will also be asked to rate their meaning in life on a scale from 0 to 10.

  5. Change from baseline Community Inclusion at 6 months [ Time Frame: Assessed during baseline testing + 6 months after inclusion ]
    Community inclusion will be measured using 1 item from the Community Integration Measure (CIM). Older participants will also be asked to rate their community inclusion on a scale from 0 to 10.

  6. Change from baseline aging well in place at 6 months [ Time Frame: Assessed during baseline testing + 6 months after inclusion ]
    One self-constructed question (1 item) will assess if the older person lives at home in a qualitative manner


Secondary Outcome Measures :
  1. Multidimensional frailty [ Time Frame: Assessed during baseline testing + 6 months after inclusion ]
    The Comprehensive Frailty Assessment Instrument (CFAI) will be used to measure multidimensional frailty: physical, cognitive, psychological, social and environmental frailty

  2. Physical phenotype of frailty [ Time Frame: Assessed during baseline testing + 6 months after inclusion ]
    The Fried's phenotype of frailty will be used to assess the physical phenotype of frailty as well as the questionnaire of Op het Veld

  3. Feeling frail [ Time Frame: Assessed during baseline testing + 6 months after inclusion ]
    The subjective feeling of frailty will be assessed using 1 self-constructed question and will assess to what extent an older person feels frail

  4. Resilience [ Time Frame: Assessed during baseline testing + 6 months after inclusion ]
    Resilience will be measured using the Connor-Davidson Resilience Scale (CD-RISC2), which is an abbreviated 2-item version of the original scale

  5. Coping [ Time Frame: Assessed during baseline testing + 6 months after inclusion ]
    Coping will be measured using 12 items from the BRIEF cope. Two items from active coping, positive reframing, religion, use of emotional support and self-distraction and one item from acceptance and behavioral disengagement will be used

  6. Help needed for activities in daily life [ Time Frame: Assessed during baseline testing + 6 months after inclusion ]
    Older people will be asked if they need help with 8 activities of daily life, and to what extent the help they receive for these activities is sufficient. These questions are adapted from the questionnaire of the Belgian Ageing Studies (BAS)

  7. Informal and formal care [ Time Frame: Assessed during baseline testing + 6 months after inclusion ]
    Older people will be asked if they receive care from 6 informal and 14 formal caregivers and if they are satisfied with the help they receive from these caregivers. These questions are adapted from the BAS-questionnaire.

  8. Medical care [ Time Frame: Assessed during baseline testing + 6 months after inclusion ]
    The participants will be asked if they needed to go to the hospital, to a residential setting and a rehabilitation center over the past 6 months (day case/overnight stay). These questions are adapted from the Health Interview Survey. In addition, the participants will be asked when they visited the general practitioner for the last time over the last 6 months.

  9. Leisure time [ Time Frame: Assessed during baseline testing + 6 months after inclusion ]
    Leisure time will be measured by using an adapted question with 8 items derived from the BAS-questionnaire and will examine how often the participants perform the listed activities

  10. Neighborhood [ Time Frame: Assessed during baseline testing + 6 months after inclusion ]
    Different dimensions of neighborhood will be assessed. First, the social environment will be administered by using 3 items from the social cohesion dimension of the Neighbourhood Scale. Second, the physical environment will be explored by using 4 items from the BAS-questionnaire as well as from the Neighbourhood Environment Walkability Scale. Finally, low-key participation will be examined by using 2 items from the questionnaire of Oswald & Konopik.

  11. Life-events [ Time Frame: Assessed during baseline testing + 6 months after inclusion ]
    A shortened version of the Geriatric Adverse Life Events Scale (GALES) will be adapted to assess to occurrence of life-events (11 items)



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   60 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

Sample 1: 150 older people per municipality (total: 3 municipalities) (inclusion criteria: at least one selection criterion)

  • Gender: 75 men - 75 women
  • Age: 25 older people aged between 60 and 70 years old - 125 older people older than 70 years
  • Marital status: 50 older people with partner - 100 older people without partner
  • Living situation: 100 older people who have not moved last 10 years - 50 older people who have moved last 10 years
  • Migration background: 100 older people born in Belgium - 50 older people born elsewhere

Sample 2: 150 older people per municipality (total: 3 municipalities) (inclusion criteria: all selection criteria at once)

  • 75 men, older than 70 years, living together/widowed/divorced/never married, moved last 10 years
  • 75 women, older than 70 years, widowed/divorced/never married, moved last 10 years

Exclusion Criteria:

  • Current institutionalization
  • Current hospitalization

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03168204


Locations
Layout table for location information
Belgium
OCMW Gent
Gent, Belgium, 9000
OCMW Knokke-Heist
Knokke-Heist, Belgium, 8300
OCMW Tienen
Tienen, Belgium, 3300
Sponsors and Collaborators
Vrije Universiteit Brussel
Hogeschool Gent
Universiteit Antwerpen
KU Leuven
Maastricht University
Agentschap voor Innovatie door Wetenschap en Technologie
Investigators
Layout table for investigator information
Principal Investigator: Liesbeth De Donder, Prof. Dr. Vrije Universiteit Brussel

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
Responsible Party: Liesbeth De Donder, Prof. Dr. Liesbeth De Donder, Vrije Universiteit Brussel
ClinicalTrials.gov Identifier: NCT03168204     History of Changes
Other Study ID Numbers: D-SCOPE IWT 140027
First Posted: May 30, 2017    Key Record Dates
Last Update Posted: April 25, 2019
Last Verified: April 2019

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No